Clincosm LogoSign in Get a demo

alk gene mutation

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Radiotherapy Side Effect, NSCLC, ALK Gene Mutation Trial in Stockholm (SBRT/SRS/radiation therapy)

Not yet recruiting
  • Radiotherapy Side Effect
  • +2 more
  • SBRT/SRS/radiation therapy
  • Stockholm, Sweden
    Karolinska University Hospital
Feb 16, 2023

NSCLC Stage IIIB, ALK Gene Mutation Trial in Mexico City (Alectinib Oral Product)

Recruiting
  • Non-small Cell Lung Cancer Stage IIIB
  • ALK Gene Mutation
  • Alectinib Oral Product
  • Mexico City, Mexico
    Thoracic Oncology Unit and Personalized Medicine Laboratory, Ins
Jan 26, 2023

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

Frequency, Clinical Phenotype and Genetic Analysis of Heritable

Not yet recruiting
  • Renal Tumor Histology
  • +13 more
  • Gene test
  • Shanghai, Shanghai, China
    Ethics Committee of Shanghai Renji Hospital
Sep 6, 2022

Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)

Recruiting
  • Lung Cancer
  • +3 more
  • Sensus Smartwatch Application
  • +3 more
  • Charlottesville, Virginia
    University of Virginia
Aug 26, 2022

Non Small Cell Lung Cancer, ALK Gene Mutation Trial in France (Brigatinib 180 MG, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • ALK Gene Mutation
  • Brigatinib 180 MG
  • +2 more
  • Angers, France
  • +31 more
Aug 9, 2022

ALK Gene Mutation, Lung Adenocarcinoma, Immunotherapy Trial in Changsha (Pembrolizumab Combined With Bevacizumab and

Not yet recruiting
  • ALK Gene Mutation
  • +2 more
  • Pembrolizumab Combined With Bevacizumab and Chemotherapy
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jul 14, 2022

French National Observatory of Non-small Cell Lung and Molecular

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +3 more
    • Agen, France
    • +132 more
    Jun 29, 2022

    Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

    Withdrawn
    • Advanced Malignant Neoplasm
    • +10 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 15, 2022

    Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI

    Recruiting
    • Non-Small Cell Carcinoma of Lung, TNM Stage 4
    • +5 more
      • Aurora, Colorado
        University of Colorado, Cancer Center
      Nov 3, 2021

      ALK Translocations in Serial Blood Samples From Non-Small Cell

      Enrolling by invitation
      • Lung Cancer
      • +3 more
      • Aarhus, Denmark
        Aarhus University Hospital
      Jan 30, 2021